169 related articles for article (PubMed ID: 9498715)
1. Clinical relevance of serum soluble interleukin-2 receptor levels in acute and chronic graft-versus-host disease.
Kobayashi S; Imamura M; Hashino S; Tanaka J; Asaka M
Leuk Lymphoma; 1997 Dec; 28(1-2):159-69. PubMed ID: 9498715
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: a true marker of acute graft-versus-host disease.
Kami M; Matsumura T; Tanaka Y; Mikami Y; Miyakoshi S; Ueyama J; Morinaga S; Mori S; Machida U; Kanda Y; Chiba S; Sakamaki H; Hirai H; Muto Y
Leuk Lymphoma; 2000 Aug; 38(5-6):533-40. PubMed ID: 10953974
[TBL] [Abstract][Full Text] [Related]
3. Serum cytokine levels after HLA-identical bone marrow transplantation.
Liem LM; van Houwelingen HC; Goulmy E
Transplantation; 1998 Oct; 66(7):863-71. PubMed ID: 9798695
[TBL] [Abstract][Full Text] [Related]
4. Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation.
Foley R; Couban S; Walker I; Greene K; Chen CS; Messner H; Gauldie J
Bone Marrow Transplant; 1998 Apr; 21(8):769-73. PubMed ID: 9603399
[TBL] [Abstract][Full Text] [Related]
5. Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease.
Miyamoto T; Akashi K; Hayashi S; Gondo H; Murakawa M; Tanimoto K; Harada M; Niho Y
Bone Marrow Transplant; 1996 Feb; 17(2):185-90. PubMed ID: 8640164
[TBL] [Abstract][Full Text] [Related]
6. Possible role of granulocyte colony-stimulating factor in increased serum soluble interleukin-2 receptor-alpha levels after allogeneic bone marrow transplantation.
Kobayashi S; Imamura M; Hashino S; Noto S; Mori A; Tanaka J; Naohara T; Kasai M; Asaka M
Leuk Lymphoma; 1999 May; 33(5-6):559-66. PubMed ID: 10342583
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-2 receptor levels in cytomegalovirus disease and graft versus host disease after T-lymphocyte depleted bone marrow transplantation for hematological neoplasias.
Engelhard D; Nagler A; Singer R; Barak V
Leuk Lymphoma; 1994 Jan; 12(3-4):273-80. PubMed ID: 8167558
[TBL] [Abstract][Full Text] [Related]
8. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-2 receptor index predicts the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors.
Nakamura Y; Tanaka Y; Tanaka M; Sugiyama A; Yamamoto K; Tokunaga Y; Yujiri T; Tanizawa Y
Int J Hematol; 2016 Apr; 103(4):436-43. PubMed ID: 26791380
[TBL] [Abstract][Full Text] [Related]
10. Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantations as a marker for GVHD.
Grimm J; Zeller W; Zander AR
Bone Marrow Transplant; 1998 Jan; 21(1):29-32. PubMed ID: 9486491
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning.
Kaida K; Ikegame K; Ikemoto J; Murata R; Irie R; Yoshihara S; Ishii S; Okada M; Inoue T; Tamaki H; Soma T; Fujimori Y; Kai S; Ogawa H
Int J Hematol; 2014 Apr; 99(4):463-70. PubMed ID: 24599414
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
Remberger M; Ringdén O
Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH
Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
[TBL] [Abstract][Full Text] [Related]
14. Soluble Interleukin-2 Receptor Index Predicts Outcomes After Cord Blood Transplantation.
Kajimura Y; Nakamura Y; Tanaka Y; Tanaka M; Yamamoto K; Matsuguma M; Tokunaga Y; Yujiri T; Tanizawa Y
Transplant Proc; 2021; 53(1):379-385. PubMed ID: 32389487
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation.
Toren A; Novick D; Or R; Ackerstein A; Slavin S; Nagler A
Transplantation; 1996 Jul; 62(1):138-42. PubMed ID: 8693533
[TBL] [Abstract][Full Text] [Related]
16. Cell surface markers and circulating cytokines in graft versus host disease.
Chang DM; Wang CJ; Kuo SY; Lai JH
Immunol Invest; 1999 Jan; 28(1):77-86. PubMed ID: 10073684
[TBL] [Abstract][Full Text] [Related]
17. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
[TBL] [Abstract][Full Text] [Related]
18. Serum elastase and antithrombin-3 levels after umbilical cord blood transplantation or bone marrow transplantation.
Toda A; Takatsuka H; Nakajima T; Nomura K; Wakae T; Itoi H; Okada M; Misawa M; Hara H
Hematology; 2007 Feb; 12(1):29-31. PubMed ID: 17364989
[TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation.
Mathias C; Mick R; Grupp S; Duffy K; Harris F; Laport G; Stadtmauer E; Luger S; Schuster S; Wasik MA; Porter DL
J Hematother Stem Cell Res; 2000 Jun; 9(3):393-400. PubMed ID: 10894361
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow transplantation for fourteen patients with severe aplastic anemia.
Hsueh EJ; Hwang WS; Huang SH; Chao TY; Chang JY; Wang CC
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Apr; 57(4):247-53. PubMed ID: 8705875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
